ArticleNature communications2024

CRISPR/Cas9 editing of NKG2A improves the efficacy of primary CD33-directed chimeric antigen receptor natural killer cells.

Tobias Bexte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.